Trials / Unknown
UnknownNCT04548401
Effect of Antiplatelet Therapy on Cognition After Aneurysmal Subarachnoid Hemorrhage
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Nanjing Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- —
Summary
Deficits in memory, executive function, and language are common cognitive sequelae of aneurysmal subarachnoid hemorrhage (aSAH). Previous study demonstrated that post-treatment antiplatelet therapy reduced risk for delayed cerebral ischemia caused by aSAH. However, the effect of antiplatelet therapy on cognition after aSAH is unclear. The aim of this study was to assess the effect of antiplatelet therapy on cognition after aSAH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Antiplatelet Drug | aspirin and/or clopidogrel or ticagrelor |
Timeline
- Start date
- 2019-11-01
- Primary completion
- 2021-10-31
- Completion
- 2021-12-31
- First posted
- 2020-09-14
- Last updated
- 2020-09-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04548401. Inclusion in this directory is not an endorsement.